Assessing the safety and performance of a new intraocular lens for cataract surgery
Official title: Multicentric Clinical Investigation to Determine Safety and Efficacy of a Hydrophobic Acrylic Multifocal Intraocular Lens
Run by Cutting Edge SAS · NCT06446817 · Data updated 2026-11-12
This study is testing a new type of lens for cataract surgery to see if it improves vision better than a standard lens for people aged 50 and older.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 57 (estimated) |
| Sponsor | Cutting Edge SAS Industry-sponsored |
| Locations | 3 sites (Marseille and 2 other locations) |
| Status | Recruiting |
| Started | December 19, 2024 |
| Main results expected | September 2028 |
| Study ends | December 2028 |
| Registry record updated | May 26, 2026 |
| Trial ID | NCT06446817 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 50 or older with bilateral cataracts who have not undergone previous refractive surgery.
✕Probably not a fit
Patients with significant ocular comorbidities or those requiring secondary surgical interventions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical investigation aims to evaluate the safety and performance of the LuxHighAdd intraocular lens (IOL) when implanted bilaterally in patients with cataracts. Participants will be compared to those receiving the LuxGood monofocal lens to determine the effectiveness of the new multifocal lens. The study will involve patients aged 50 and over who meet specific eligibility criteria, ensuring a controlled environment for accurate results. The primary focus is on the outcomes related to vision improvement and safety post-implantation.
Why it matters
Potential benefit: If successful, this study could provide patients with improved vision outcomes following cataract surgery through the use of a new multifocal lens.
How similar studies have gone: Other studies have shown promising results with multifocal intraocular lenses, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject aged 50 or over on the day of inclusion, presenting a bilateral cataract, qualified for bilateral implantation * No ocular comorbidity possibly affecting the study results * Fit within the available IOL diopter range * Have had no previous refractive surgery * Regular corneal astigmatism ≤1.0 dioptres * Clear intraocular media other than cataract * Availability, willingness and sufficient cognitive awareness to comply with examination procedures * Ability to attend all study follow-ups * Signed informed consent. Exclusion Criteria: * Ocular surface disease potentially affecting study results * Pre-existing ocular pathology or history of pathology potentially affecting the study results * Acute or chronic disease or illness that would increase risk or confound study results * Subjects who may be reasonably expected to require a secondary surgical intervention at any time during the investigation (other than YAG capsulotomy) * Axial lengths and keratometry such as the IOL spherical power is not in the range of 16 to 26 D * Instability of keratometry or biometry measurements * Traumatic cataract * Amblyopia * History of ocular trauma or any prior ocular surgery including refractive procedures * Capsular or zonular abnormalities that may affect postoperative centration or tilt of the lens * Pupil abnormalities * Systemic or ocular medication that could modify pupil dynamics * Expected complicated surgery or complicated surgery * Concurrent participation in another drug or device investigation
Where it's running
-
Centre d'Ophtalmologie des Dr Rozot et associés
Marseille, France Recruiting -
Clinique Honoré Cave
Montauban, France Recruiting -
Hôpital Fondation Adolphe de Rothschild
Paris, France Recruiting
Study contacts
- Principal investigator: Alain Saad, MD — Hôpital Fondation Adolphe de Rothschild
- Study coordinator: Line Bettinelli, OD
- Email: line.bettinelli@bausch.com
- Phone: 0619530701
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rotational Stability of the Acunex Vario Toric
This study tests whether the Acunex Vario toric extended-depth-of-focus intraocular lens stays stable in rotation and effectively reduces astigmatism for people undergoing cataract surgery.
-
Anterior segment anatomy assessment with swept-source OCT in eye surgery patients
This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.
-
MiLOOP-assisted cataract surgery for dense cataracts
In people with dense cataracts, this study tests whether using the miLOOP device during cataract surgery can protect corneal cells and reduce ultrasound energy, compared with standard surgery.
-
Visual adaptation and quality of life after different IOL implantation options
This study follows adults who have cataracts and receive bilateral multifocal or mixed IOLs to see how their vision and daily life improve over 6 months.
-
Corneal Biomechanics and Surgical Astigmatism after Cataract Surgery in Pseudoexfoliation
This study tests how the cornea's biomechanical properties before cataract surgery relate to the amount of blinking surgically induced astigmatism, comparing people with pseudoexfoliation to those without.
-
Neuroplastic pain education and guided breathing during awake cataract surgery
This trial tests whether the STEIN Protocol, a non-drug approach with pain education, guided imagery, and paced breathing, helps adults having cataract surgery require less pain medicine and feel less anxious.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.